TITLE

Pathology/cytology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS73
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Colitis in interleukin-10 gene knock-out mice is attenuated by metronidazole and ciprofloxacin,' by J.S.G. Doyle et al.
ACCESSION #
9708236890

 

Related Articles

  • Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. McCarthy, J.; O'Mahony, L.; O'Callaghan, L.; Sheil, B.; Vaughan, E.E.; Fitzsimons, N.; Fitzgibbon, J.; O'Sullivan, G.C.; Kiely, B.; Collins, J.K.; Shanahan, F. // Gut;Jul2003, Vol. 52 Issue 7, p975 

    Background: Prophylactic efficacy against colitis following lactobacillus consumption in interleukin 10 (IL-10) knockout (KO) mice has been reported. Whether this applies equally to other probiotic strains is unknown, and the mechanism is unclear. Aims: (1) To compare the effect of feeding...

  • Amitriptyline.  // Reactions Weekly;9/8/2007, Issue 1168, p6 

    The article describes the case of a man who developed ischaemic colitis while receiving amitriptyline for depression. With the long-term treatment with amitriptyline 50 mg/day, the man developed loss of consciousness, abdominal pain, vomiting and bloody diarrhoeas, and ischaemic colitis was...

  • IL-i OR polymorphisms are associated with very-early- onset ulcerative colitis. Muise, A. M. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p109 

    A review of the article "IL-1OR polymorphisms are associated with very-early- onset ulcerative colitis," by C. J. Moran and colleagues, which appeared in the 2013 issue of the periodical "Inflammatory Bowel Disease," is presented.

  • Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Lindsay, J.O.; Ciesielski, C.J.; Scheinin, T.; Brennan, F.M.; Hodgson, H.J. // Gut;Jul2003, Vol. 52 Issue 7, p981 

    Introduction: Interleukin 10 knockout (IL-10-/-) mice spontaneously develop a Th1 T cell mediated colitis with many similarities to Crohn's disease. Daily injections of IL-10 are unable to induce remission in mice with established disease. In contrast, we have shown previously that intravenous...

  • Ciprofloxacin/glimepiride/metronidazole.  // Reactions Weekly;1/29/2011, Issue 1336, p13 

    The article describes the case of a 79-year-old man who presented with hypoglycaemia while receiving treatment with ciprofloxacin, glimepiride and metronidazole, referencing a study published in the December 2010 issue of the journal "Hospital Pharmacy."

  • Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice. Hoentjen, F.; Harmsen, H. J. M.; Braat, H.; Torrice, C. D.; Mann, B. A.; Sartor, R. B.; Dieleman, L. A. // Gut;Dec2003, Vol. 52 Issue 12, p1721 

    Background and aims: Multiple rodent models implicate resident intestinal bacteria in the pathogenesis of chronic immune mediated intestinal inflammation. Specific pathogen free (SPF) interleukin 10 gene deficient (IL-10-/-) mice develop colitis, which does not occur in the germ free (GF) state....

  • CXCR3 Axis: Role in Inflammatory Bowel Disease and its Therapeutic Implication. Singh, Udai P.; Venkataraman, Chandrasekar; Singh, Rajesh; Lillard Jr., James W. // Endocrine, Metabolic & Immune Disorders - Drug Targets;Jun2007, Vol. 7 Issue 2, p111 

    There is a great need for new intervention and prevention strategies against Crohn's disease (CD), a chronic, relapsing tissue-destructive inflammatory bowel disease (IBD). Estimates indicate more than 1 million cases of IBD in the United States occur annually, with 50% involving CD. The...

  • Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Franke, Andre; Balschun, Tobias; Karlsen, Tom H; Sventoraityte, Jurgita; Nikolaus, Susanna; Mayr, Gabriele; Domingues, Francisco S; Albrecht, Mario; Nothnagel, Michael; Ellinghaus, David; Sina, Christian; Onnie, Clive M; Weersma, Rinse K; Stokkers, Pieter C F; Wijmenga, Cisca; Gazouli, Maria; Strachan, David; McArdle, Wendy L; Vermeire, Séverine; Rutgeerts, Paul // Nature Genetics;Nov2008, Vol. 40 Issue 11, p1319 

    Inflammatory bowel disease (IBD) typically manifests as either ulcerative colitis (UC) or Crohn's disease (CD). Systematic identification of susceptibility genes for IBD has thus far focused mainly on CD, and little is known about the genetic architecture of UC. Here we report a genome-wide...

  • Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. Imaoka, Akemi; Shima, Tatsuichiro; Kato, Kimitoshi; Mizuno, Shigeaki; Uehara, Toshiki; Matsumoto, Satoshi; Setoyama, Hiromi; Hara, Taeko; Usemsaki, Yoshinori; Pravda, Jay; Costa, Francisco // World Journal of Gastroenterology;4/28/2008, Vol. 14 Issue 16, p2511 

    AIM: To determine the anti-inflammatory activity of probiotic Bifidobacteria in Bifidobacteria-fermented milk (BFM) which is effective against active ulcerative colitis (UC) and exacerbations of UC, and to explore the immunoregulatory mechanisms. METHODS: Peripheral blood mononuclear cells...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics